Global CDMO footprint AGC Pharma Chemicals operates in Spain and Japan with a focus on small molecule APIs and intermediates, presenting opportunities to upsell development and manufacturing partnerships across Europe and Asia for global pharma clients seeking regionalized supply and cross-border capabilities.

Next-gen API facility The completion and inauguration of a next-generation API/HPAPI manufacturing facility in Barcelona signals capacity for scaled production, enabling outreach to clients needing scalable, compliant manufacturing with potential for diversified API portfolios and faster time-to-market.

Award winning ops Recent Best in Class distinctions in CDMO Leadership Awards for staff, cultural fit, technology use, and scaling support bolster credibility when engaging prospective customers, especially those prioritizing strong operational excellence and tech-enabled supply chains.

Active industry engagement Participation in events like BioSpain, ChemOutsourcing, BOS Basel, and BIO International Convention, plus regional connections in Catalonia, provides frequent in-person and virtual touchpoints to generate leads, showcase capabilities, and identify co-development or out-licensing opportunities.

Sustainable growth posture Investment in sustainable innovation and a focus on next-generation manufacturing aligns with customer demand for environmentally responsible APIs, offering potential for joint sustainability initiatives, CO2 reductions, and long-term supplier commitments.